Under construction – not a live service
Sign in
Taking people in BrazilNo phase

Tests a sleep breathing device in people recovering from ischemic stroke

Tests CPAP, a breathing device for sleep apnea, in adults with ischemic stroke.

Plain-language title generated from the registry record
Registry title: Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke

Key facts

Where
Ribeirão Preto, BrazilSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07044830, who can take part

Where in Brazil

  • Hospital das Clínicas, Ribeirão Preto Medical School, University of São PauloRibeirão Preto, BrazilTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hospital das Clínicas de Ribeirão Preto
Trial code
NCT07044830
Record updated
1 July 2025
Original description
The study aims to evaluate whether early treatment of obstructive sleep apnea with continuous positive airway pressure in ischemic stroke patients has a favorable effect on functional recovery.Read full original descriptionShow less

Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke - A Randomized Clinical Trial

The study aims to evaluate whether early treatment of obstructive sleep apnea with continuous positive airway pressure in ischemic stroke patients has a favorable effect on functional recovery.

Inclusion: Supratentorial non-lacunar ischemic stroke, including anterior, middle, and posterior cerebral artery territories; Aged 18 to 80 years; Symptom onset or symptom recognition to admission < 12 hours; NIHSS score ≥ 4 and ≤ 20 at enrollment; Signed informed consent form obtained from the participant or their legal representative.

Exclusion: Prior stroke; Previous diagnosis of OSA with current CPAP use or previously failed CPAP; Oxygen therapy >2 L/min; Chronic alcohol or drug use with high risk of withdrawal during hospitalization; Pre-stroke disability (mRS > 1); Clinical instability or severe pre-existing illness (e.g., heart failure, oxygen-dependent COPD, renal or hepatic failure); Known severe neurological disease (e.g., dementia, Parkinson's disease, multiple sclerosis, or other neurodegenerative conditions); Coma or stupor; Orotracheal intubation; Psychomotor agitation; High likelihood of neurosurgical intervention within the first 48 hours; Pregnant or suspected pregnant women; Inability to complete follow-up for any reason; Any contraindication to CPAP use.

ClinicalTrials.gov NCT07044830